INOVIO Announces Proposed Public Offering to Fuel Growth and Innovation PLYMOUTH MEETING, PA – July 2, 2025 – INOVIO, a biotechnology company dedicated to developing DNA-based vaccines and therapies, announced today its intention to conduct a proposed public offering of its common stock. This strategic move aims to bolster the company’s financial position and support … Read more
TRICARE Announces Temporary Payment Suspension for Certain Services FOR IMMEDIATE RELEASE [City, State] – July 2, 2025 – TRICARE, the healthcare program for uniformed service members, retirees, and their families, has announced a temporary suspension of payments for a specific category of services. This update, released by PR Newswire Healthring, aims to ensure the continued … Read more
Sleep Apnea Market Poised for Significant Growth: DelveInsight Report Highlights 20% CAGR [City, State] – July 2, 2025 – The global sleep apnea market is projected to experience substantial acceleration, with an impressive Compound Annual Growth Rate (CAGR) of 20% anticipated during the study period of 2020-2034. This optimistic forecast comes from a comprehensive report … Read more
Ascletis® Pharmaceuticals Commences Phase IIa Study of Oral GLP-1R Agonist ASC30 in U.S. for Obesity and Overweight Patients [City, State] – July 2, 2025 – Ascletis Pharmaceuticals (HKEX: 1672), a leading biopharmaceutical company, today announced a significant milestone in its ongoing commitment to addressing metabolic diseases. The company has successfully dosed the first participants in … Read more
Neurizon Secures Global License with Elanco for NUZ-001, Ushering in a New Era for Animal Health [City, State] – July 2, 2025 – Neurizon, a pioneering biopharmaceutical company dedicated to advancing animal health, today announced a significant milestone with the signing of a global licensing agreement with Elanco Animal Health Incorporated (NYSE: ELAN), a global … Read more
Here’s an article about the Neurizon and Elanco licensing agreement: Neurizon Secures Global License with Elanco, Paving the Way for Accelerated Commercialization of NUZ-001 [City, State] – July 2, 2025 – Neurizon, a forward-thinking biopharmaceutical company dedicated to advancing novel therapeutic solutions, today announced a significant milestone: the signing of a global license agreement with … Read more
Lake Chelan Health Forges Strategic Partnership with Medline to Enhance Patient Care and Operational Efficiency CHELAN, WA – July 2, 2025 – Lake Chelan Health (LCH), a leading healthcare provider serving the Chelan Valley and surrounding communities, today announced it has entered into a comprehensive prime vendor agreement with Medline, a global manufacturer and distributor … Read more
Promising Advancement in Autoimmune Disease Treatment: Jacobio’s JAB-8263 Clears Regulatory Hurdle for Clinical Trials New York, NY – July 3, 2025 – Jacobio Pharmaceuticals, a clinical-stage biopharmaceutical company, announced today that its Investigational New Drug (IND) application for JAB-8263, a novel BET inhibitor, has been accepted by the U.S. Food and Drug Administration (FDA) for … Read more
Safe Life Acquires Salvavidas Cardio, Marking Entry into the Spanish AED Market [City, State] – July 3, 2025 – Safe Life, a prominent provider of Automated External Defibrillators (AEDs) and associated life-saving technologies, today announced its strategic acquisition of Salvavidas Cardio, a well-established player in the Spanish market. This significant move marks Safe Life’s official … Read more
Probiotics in Animal Feed Market Poised for Significant Growth, Expected to Reach $8.27 Billion by 2030 NEW YORK, July 3, 2025 – The global market for probiotics in animal feed is on track for substantial expansion, with projections indicating it will reach an impressive $8.27 billion by the year 2030. This significant growth is detailed … Read more